David E. Kloecker

540 total citations
15 papers, 308 citations indexed

About

David E. Kloecker is a scholar working on Endocrinology, Diabetes and Metabolism, Clinical Psychology and Oncology. According to data from OpenAlex, David E. Kloecker has authored 15 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Clinical Psychology and 3 papers in Oncology. Recurrent topics in David E. Kloecker's work include Diabetes Treatment and Management (8 papers), Diabetes Management and Research (5 papers) and COVID-19 and Mental Health (3 papers). David E. Kloecker is often cited by papers focused on Diabetes Treatment and Management (8 papers), Diabetes Management and Research (5 papers) and COVID-19 and Mental Health (3 papers). David E. Kloecker collaborates with scholars based in United Kingdom, Italy and Australia. David E. Kloecker's co-authors include Kamlesh Khunti, Melanie J. Davies, Francesco Zaccardi, Cameron Razieh, Nazrul Islam, Yogini Chudasama, Clare Gillies, Thomas Yates, Alex V. Rowlands and Nafeesa Dhalwani and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Mayo Clinic Proceedings.

In The Last Decade

David E. Kloecker

13 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David E. Kloecker United Kingdom 10 87 60 47 46 40 15 308
Carolina Knott-Torcal Spain 5 62 0.7× 58 1.0× 91 1.9× 54 1.2× 43 1.1× 8 313
Linong Ji China 9 175 2.0× 66 1.1× 29 0.6× 70 1.5× 49 1.2× 23 390
Ladislav Štěpánek Czechia 10 80 0.9× 43 0.7× 25 0.5× 48 1.0× 65 1.6× 34 303
Louise Newson United Kingdom 11 78 0.9× 29 0.5× 65 1.4× 53 1.2× 22 0.6× 37 428
Sailesh Sankar United Kingdom 9 58 0.7× 49 0.8× 30 0.6× 19 0.4× 35 0.9× 29 252
Anwar A. Jammah Saudi Arabia 10 134 1.5× 105 1.8× 32 0.7× 123 2.7× 50 1.3× 35 458
Hongmei Yang China 10 48 0.6× 37 0.6× 24 0.5× 54 1.2× 72 1.8× 28 368
Guiying Dong China 7 61 0.7× 21 0.3× 29 0.6× 109 2.4× 41 1.0× 12 324
Aarti Thakkar United States 9 48 0.6× 23 0.4× 18 0.4× 58 1.3× 53 1.3× 21 325
Pieralessandro Lasalvia Colombia 10 54 0.6× 73 1.2× 13 0.3× 12 0.3× 25 0.6× 52 336

Countries citing papers authored by David E. Kloecker

Since Specialization
Citations

This map shows the geographic impact of David E. Kloecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Kloecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Kloecker more than expected).

Fields of papers citing papers by David E. Kloecker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Kloecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Kloecker. The network helps show where David E. Kloecker may publish in the future.

Co-authorship network of co-authors of David E. Kloecker

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Kloecker. A scholar is included among the top collaborators of David E. Kloecker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Kloecker. David E. Kloecker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Rizzi, Alessandro, David E. Kloecker, Dario Pitocco, et al.. (2024). Effect of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on time to outcome in type 2 diabetes cardiorenal outcome trials. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 18(2). 102945–102945.
2.
Kloecker, David E., Melanie J. Davies, Dario Pitocco, Kamlesh Khunti, & Francesco Zaccardi. (2023). Intensive glucose control and recurrent cardiovascular events: 14‐year follow‐up investigation of the ACCORDION study. Diabetes/Metabolism Research and Reviews. 39(5). e3634–e3634.
3.
Zaccardi, Francesco, Katherine Byrne, Kamlesh Khunti, et al.. (2023). The impact of COVID-19 lockdowns on the body mass index of people living with obesity: A UK retrospective cohort study using the UK Clinical Practice Research Datalink. Obesity Research & Clinical Practice. 17(6). 468–476. 3 indexed citations
4.
Zaccardi, Francesco, David E. Kloecker, Kamlesh Khunti, & Melanie J. Davies. (2022). Non‐inferiority and clinical superiority of glucagon‐like peptide‐1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors: Systematic analysis of cardiorenal outcome trials in type 2 diabetes. Diabetes Obesity and Metabolism. 24(8). 1598–1606. 3 indexed citations
5.
Rowlands, Alex V., Paddy C. Dempsey, Clare Gillies, et al.. (2021). Association Between Accelerometer-Assessed Physical Activity and Severity of COVID-19 in UK Biobank. SHILAP Revista de lepidopterología. 5(6). 997–1007. 22 indexed citations
6.
Kloecker, David E., Kamlesh Khunti, Melanie J. Davies, Dario Pitocco, & Francesco Zaccardi. (2021). Microvascular Disease and Risk of Cardiovascular Events and Death From Intensive Treatment in Type 2 Diabetes. Mayo Clinic Proceedings. 96(6). 1458–1469. 14 indexed citations
7.
Chudasama, Yogini, Francesco Zaccardi, Clare Gillies, et al.. (2021). Patterns of multimorbidity and risk of severe SARS-CoV-2 infection: an observational study in the U.K.. BMC Infectious Diseases. 21(1). 908–908. 48 indexed citations
8.
Rowlands, Alex V., Clare Gillies, Yogini Chudasama, et al.. (2021). Association of working shifts, inside and outside of healthcare, with severe COVID−19: an observational study. BMC Public Health. 21(1). 773–773. 23 indexed citations
9.
Razieh, Cameron, Francesco Zaccardi, Nazrul Islam, et al.. (2021). Ethnic minorities and COVID-19: examining whether excess risk is mediated through deprivation. European Journal of Public Health. 31(3). 630–634. 24 indexed citations
10.
Kloecker, David E., Melanie J. Davies, Kamlesh Khunti, & Francesco Zaccardi. (2021). Cardiovascular effects of sodium‐glucose co‐transporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists: The P value and beyond. Diabetes Obesity and Metabolism. 23(7). 1685–1691. 5 indexed citations
11.
Rowlands, Alex V., David E. Kloecker, Yogini Chudasama, et al.. (2020). Association of Timing and Balance of Physical Activity and Rest/Sleep With Risk of COVID-19: A UK Biobank Study. Mayo Clinic Proceedings. 96(1). 156–164. 30 indexed citations
12.
Zaccardi, Francesco, Kamlesh Khunti, Melanie J. Davies, et al.. (2020). Efficacy and tolerability of sodium‐glucose co‐transporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists: A systematic review and network meta‐analysis. Diabetes Obesity and Metabolism. 22(7). 1035–1046. 53 indexed citations
13.
Kloecker, David E., Melanie J. Davies, Kamlesh Khunti, & Francesco Zaccardi. (2020). Uses and Limitations of the Restricted Mean Survival Time: Illustrative Examples From Cardiovascular Outcomes and Mortality Trials in Type 2 Diabetes. Annals of Internal Medicine. 172(8). 541–552. 55 indexed citations
14.
Davies, Melanie J., David E. Kloecker, David R. Webb, Kamlesh Khunti, & Francesco Zaccardi. (2020). Number needed to treat in cardiovascular outcome trials of glucagon‐like peptide‐1 receptor agonists: A systematic review with temporal analysis. Diabetes Obesity and Metabolism. 22(9). 1670–1677. 12 indexed citations
15.
Kloecker, David E., et al.. (2019). Efficacy of low‐ and very‐low‐energy diets in people with type 2 diabetes mellitus: A systematic review and meta‐analysis of interventional studies. Diabetes Obesity and Metabolism. 21(7). 1695–1705. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carolina Knott-Torcal Breakdown of academic impact, for papers by Linong Ji Breakdown of academic impact, for papers by Ladislav Štěpánek Breakdown of academic impact, for papers by Louise Newson Breakdown of academic impact, for papers by Sailesh Sankar Breakdown of academic impact, for papers by Anwar A. Jammah Breakdown of academic impact, for papers by Hongmei Yang Breakdown of academic impact, for papers by Guiying Dong Breakdown of academic impact, for papers by Aarti Thakkar Breakdown of academic impact, for papers by Pieralessandro Lasalvia
Rankless by CCL
2026